Consigue una respuesta de este empleador
Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.
Genmab is seeking a Director to lead early commercial strategy for the oncology portfolio, partnering with cross-functional teams to inform development pathways and market access. The role requires a track record of strategic leadership in biopharma, strong communication, and the ability to navigate ambiguity in a global organization.
This position reports to the VP, Global Commercialization, Oncology and involves shaping portfolio priorities, indications, and pathways to market as products
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
Reporting to the VP, Global Commercialization, Oncology, the Director will be a key member of the Genmab Global Strategic Marketing Team, providing strategic commercial leadership for early-stage assets in the Genmab pipeline. The Director will assess evolving competitive landscapes, unmet patient needs, and global market dynamics to evaluate commercial potential and prioritize development strategies. This role will partner with internal cross-functional stakeholders and external alliance partners to inform optimal paths to market for assigned products in development. The Director will develop early commercial and portfolio strategies, shape differentiated asset strategies and development priorities, and drive cross-functional alignment on indication prioritization and pathways to market as products progress toward late-stage development
The successful candidate will bring a strong track record of strategic thinking, influence, and leadership in the biopharmaceutical industry. The Director will effectively manage complex projects, make decisions amid ambiguity, influence cross-functional stakeholders, build relationships across the organization, and communicate effectively in a fast-paced, multicultural environment.
For US based candidates, the proposed salary band for this position is as follows:
$205,632.00---$308,448.00The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.
When you join Genmab, you’re joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for:
Further details on eligibility for compensation and benefits based on role will be provided during the recruitment process
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed-term employment contract.